Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. - Wikidata - awgldk - TriplyDB

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis.

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis.

http://www.wikidata.org/entity/Q44644559

about

Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System Future directions for the early detection of recurrent breast cancer Progress in circulating tumor cell capture and analysis: implications for cancer management Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma.Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.Clinical significance of circulating tumor cells in breast cancer patients.Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.Circulating tumor cells: from bench to bedside Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood Detection of disseminated tumor cells in peripheral blood.Biomarkers characterization of circulating tumour cells in breast cancer patients Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy.The measurement and therapeutic implications of circulating tumour cells in breast cancer.Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression Separation of tumor cells with dielectrophoresis-based microfluidic chip Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?The prognostic implications of circulating tumor cells in patients with breast cancer.Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.Circulating tumor cells as prognostic marker in metastatic breast cancer.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Efficacy and pharmacogenomic biomarkers in breast cancer.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status.CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy.Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer.CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors.APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system.HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture?Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome.Detection of Disseminated Cancer Cells in Blood.

P2860

Q26796208-8BC59380-C848-4BB4-889E-9AF6173C6EE4 Q27022040-F80DDC08-93C4-4A1D-8EB1-028939F216B4 Q27025737-2EEBBEF5-B0BA-4475-B362-29628D3B5423 Q30955321-8ABC5550-4930-4A32-8F0A-D834DB33D1A6 Q33285246-68CA4AD3-ED89-4E30-A8DE-5973E7BFD9F5 Q33320704-4D537832-1204-427D-B3B0-3E7DCE606DC7 Q33879583-94DDDA8F-5FD4-47C9-B005-8E8AAC54E9CD Q34286198-2237E8C1-425C-413F-B413-E64657674F13 Q34307782-095075D3-ACCF-46FF-B434-B723F052A6B6 Q35563888-2AAE35C5-91C2-47C3-8740-C8E572DCF79F Q36154564-4CC64DC5-A03E-4DE4-92E9-0FAE90262B26 Q36245346-CB47A7A1-BA48-49D9-AE9C-8EC7040621E4 Q36285641-6235466D-BB26-4BD5-BA65-B3E3F823CE95 Q36326722-19EAD57B-99CB-40F3-B7E0-AB0EA3CA85CE Q36511536-3A6037A8-33AC-4153-9FE0-06745BC7AB98 Q36564867-BA598966-C2D5-4373-87C1-0E5B26B740C2 Q36725183-BDA99799-378D-41AE-A085-56573C8FB7F0 Q36934364-6084CF32-7D74-48B9-BB58-E608396A4AFE Q36974719-378FAFC8-C9A6-49EF-84A8-F7876F351161 Q37079905-21410567-61E9-4699-8B4D-2053373F93B6 Q37360230-B6962463-7E42-4EAA-8290-7E5B27F427DC Q37687372-01448B81-B705-4715-AE08-ADF7C2F57ABC Q37908134-99767FCD-0174-433A-8152-B40A44C7372C Q37997046-3E0CC4FC-EBC1-4469-98C2-E9E40A55EFD0 Q38047337-1BAE9D9A-FB03-4BDA-8A20-469FF2963CE8 Q38097525-3A6B2EFB-0657-486F-8198-47D5AE67CF65 Q39117990-4EF587CF-C28E-46B3-AF5B-38BC3F9451AE Q39153898-8719FCBB-8235-46DD-8DFB-76C992D4AA9E Q39512212-3E64692E-147F-4781-91B3-8E77B7BC4D76 Q41167106-18B01AFE-BE97-4406-9B9D-2C134FD64425 Q41877140-0A9BB4A1-C61C-4DB6-9E64-0F5D512BD82A Q45733272-CF1388D4-B59D-4908-9B0A-425AF9C2D653 Q46713075-8FE67E80-B9B5-4EAF-A18A-570611F42D7E Q47715917-035F125E-C2BA-4177-9598-B736DE3B1B87 Q50199981-77BCAB72-55CB-4B95-8698-C136887D7430 Q51368514-0D0D0678-E07B-4F9E-8263-05764DA403C8 Q52645858-B7014BE9-9341-4FA2-A710-393030D74AE1 Q53433076-858669B3-7E18-44D3-AA30-3EAF88A4DEA9 Q55333294-5D8C07CD-58F3-4322-8280-43625D1F1E18

P2860

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis.

http://www.wikidata.org/entity/Q44644559

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Detection of breast cancer cel ...... d predicts for poor prognosis.

@en

Detection of breast cancer cel ...... d predicts for poor prognosis.

@nl

type

label

Detection of breast cancer cel ...... d predicts for poor prognosis.

@en

Detection of breast cancer cel ...... d predicts for poor prognosis.

@nl

prefLabel

Detection of breast cancer cel ...... d predicts for poor prognosis.

@en

Detection of breast cancer cel ...... d predicts for poor prognosis.

@nl

P1433

Q44644559-27FB4389-32FA-4A9E-9DBE-EA1B76B7E4FC

P1476

Q44644559-C2846250-022D-46C2-8834-AB15A92DB6D0

P2093

Q44644559-081533A5-82AA-45D4-8518-583A43465693

Q44644559-0F9E523A-97AD-4D0E-AFA8-3D24D9E5AAED

Q44644559-130D9072-BDE8-4907-ADDB-98D35B583D07

Q44644559-22734522-0579-4E6C-BD26-C90FE57F769C

Q44644559-3AA84B62-3811-43B4-A9B5-FD37A6D82F26

Q44644559-5593C425-57FF-4CFD-9013-0CA2B7D94D87

Q44644559-E06FDBDB-8CEA-4DC1-BA8F-2105189A37C4

Q44644559-EF38A582-41E5-46C3-8AA1-2A36F55076EC

Q44644559-EF689291-AB1A-4ABC-9322-0FAEB7DCA733

P2860

Q44644559-22B8F071-49A6-44E5-B0C8-4E80481C899D

Q44644559-34811998-3A56-4759-8F1E-97D8C6FFCF39

Q44644559-36A97DB1-8553-4475-B741-147A44C7C3EA

Q44644559-3C4B9B26-2528-4087-A29F-A4E58A788F29

Q44644559-D3920988-9071-420E-B507-14EE9DAB595D

Q44644559-E4CF94B8-6CD9-4FEE-AB34-236C22FB8452

Q44644559-E743C377-D97E-41EC-BB0E-930C084CEDA3

Q44644559-F89A5D77-2385-498F-B09E-102CFD790853

Q44644559-FD712C94-D7A3-413B-8AED-8B681E949ED3

P304

Q44644559-C08FD665-898D-4AF7-8BA8-1A24C8F6D031

P31

Q44644559-633B3CA5-05B2-44AC-B28C-8AF5F9D28245

P356

Q44644559-47FD72EB-61AD-4E45-AEA1-F6E878CFC80D

P433

Q44644559-4D1E310F-F955-41ED-9AD5-EC1BE7996743

P478

Q44644559-60416545-121E-4FB0-B5DD-32418D285278

P50

Q44644559-05732ABE-E516-40C2-BE18-D5A674B36AA5

P577

Q44644559-47E39D3B-A551-4F46-892F-0BA0D01E81A0

P5875

Q44644559-7DB80BF4-7073-4255-904D-2700AB0F8113

P698

Q44644559-96F2546A-67DC-4D8C-A096-718F3C578943

P356

P1433

International Journal of Cancer

P1476

Detection of breast cancer cel ...... d predicts for poor prognosis.

@en

P2093

Ana Lozano

http://www.w3.org/2001/XMLSchema#string

Antonio Sirvent

http://www.w3.org/2001/XMLSchema#string

Ignacio Algarra

http://www.w3.org/2001/XMLSchema#string

María Campos

http://www.w3.org/2001/XMLSchema#string

María-José Serrano

http://www.w3.org/2001/XMLSchema#string

Miguel Delgado-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Nicolás de la Torre

http://www.w3.org/2001/XMLSchema#string

Pedro Sanchez-Rovira

http://www.w3.org/2001/XMLSchema#string

Rosario Dueñas

http://www.w3.org/2001/XMLSchema#string

P2860

Detection and characterization of carcinoma cells in the blood

Apoptotic action of estrogen.

Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.

Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors

Pitfalls in the detection of disseminated non-hematological tumor cells.

Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.

Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.

Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up.

P304

984-990

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.11479

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

José Juan Gaforio

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5365313

http://www.w3.org/2001/XMLSchema#string

P698

14601059

http://www.w3.org/2001/XMLSchema#string